MOR208, MorphoSys

• A Fc-optimized antibody to treat B-cell malignancies (incl. CLL/SLL, B-ALL & NHL)
• Target: CD19

Additional Information:

• Product page on MOR208
• Study information on ClinicalTrials.gov